These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6110633)

  • 1. Antiarrhythmic activity of cetiedil and its analogues.
    Haring J; Mesangeau D; Huet Y; Aurousseau M
    Int J Clin Pharmacol Ther Toxicol; 1980 Nov; 18(11):467-81. PubMed ID: 6110633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological findings on cetiedil.
    Boissier JR; Aurousseau M; Giudicelli JF; Duval D
    Arzneimittelforschung; 1978; 28(12):2222-8. PubMed ID: 582934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic and hemodynamic effects of prifuroline.
    Benharkate M; Plassard G; Legeai J; Worcel M
    Arzneimittelforschung; 1986 Dec; 36(12):1761-7. PubMed ID: 3566836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection by antiarrhythmic drugs against ischemia-induced arrhythmias occurring during coronary artery occlusion in the rat.
    Gerbsch S; Hagen A
    Biomed Biochim Acta; 1987; 46(8-9):S572-5. PubMed ID: 3435514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiarrhythmic action of 3-carbethoxyamino-5-dimethylaminoacetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS -15) on experimental arrhythmia induced by aconitin, ouabain, calcium chloride and barium chloride].
    Femmer K; Poppe H; Heer S; Bartsch R
    Pharmazie; 1985 Dec; 40(12):836-40. PubMed ID: 3841597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological research on bonnecor and its metabolites].
    Poppe H; Heer S; Barch R
    Farmakol Toksikol; 1990; 53(3):46-8. PubMed ID: 2387381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological considerations on cetiedil, a drug with prevalent hemodynamic activity].
    Marmo E; Caputi A; Rossi F; Lampa E; Giordano L; Vacca C; Alise G; Somma A; Imperatore A
    Clin Ter; 1979 Jul; 90(1):11-45. PubMed ID: 535327
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of B-HT 920 on cardiotoxic effects of ouabain in guinea pigs.
    Thomas GP; Kaushal R; Tripathi RM
    Indian J Exp Biol; 1991 Nov; 29(11):1084-6. PubMed ID: 1687739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of ST-93 against ouabain induced arrhythmias in guinea pigs.
    Tripathi RM; Kaushal R; Veeranjaneyulu A
    Indian J Physiol Pharmacol; 1987; 31(2):111-6. PubMed ID: 3666879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of creatinol O-phosphate (COP) on some experimental arrhythmias in vitro and in vivo.
    Ferrini R; Miragoli G
    Arzneimittelforschung; 1979; 29(9a):1475-7. PubMed ID: 575497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic effect of KB-944, a new calcium antagonist. A comparison with verapamil and diltiazem.
    Yoshidomi M; Sukamoto T; Morita T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1056-9. PubMed ID: 6890826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of alkyl substitution in drugs. XIX. Synthesis and pharmacological properties of a series of 1-(diarylmethoxy)-3-(isopropylamino)-2-propanol hydrochlorides showing antiarrhythmic activity.
    De Vries J; Nauta WT; Timmerman H; van Hell G; Mulder D
    Arzneimittelforschung; 1968 Sep; 18(9):1200-3. PubMed ID: 5755937
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of a benzotriazinium salt on in vitro and in vivo arrhythmias in guinea-pigs and mice.
    Scott NC; French AM
    Arch Int Pharmacodyn Ther; 1980 Nov; 248(1):154-65. PubMed ID: 7212873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-arrhythmia properties of pyromecaine].
    Zakusov VV; Prianishnikova NT; Cherniakova IV; Samvelian VM; L'vov MV
    Farmakol Toksikol; 1983; 46(5):32-7. PubMed ID: 6628657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic effects of LR-A/113 a new calcium antagonistic drug.
    Stella L; de Novellis V; Vacca C; Guarino A; Cantoni V; Fici F; Rossi F
    Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):235-48. PubMed ID: 8884994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochloride.
    Alexanian AR; Arutyunian NS; Galoyan AA
    Arzneimittelforschung; 1996 Dec; 46(12):1110-3. PubMed ID: 9006783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic profile and endothelial action of novel decahydroquinoline derivatives.
    Kozlovski VI; Vdovichenko VP; Chlopicki S; Malchik SS; Praliyev KD; Zcilkibayev OT
    Pol J Pharmacol; 2004; 56(6):767-74. PubMed ID: 15662089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.